Literature DB >> 6800691

Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.

M Heikkilä, M Haukkamaa, T Luukkainen.   

Abstract

A levonorgestrel-releasing intrauterine contraceptive device was used by 10 breast-feeding women beginning 6 weeks after delivery. Two models of IUD were used. One released 10 microgram (5 patients), the other 30 microgram (5 patients) of levonorgestrel per day. Plasma and milk samples were collected 8 times over a 3-month period and the concentrations of levonorgestrel determined by radioimmunoassay. An improved and sensitive method for the determination of levonorgestrel in milk was developed. A column chromatographic purification of a milk extract before radioimmunoassay made possible the use of large milk samples in order to improve the sensitivity. The plasma concentrations during the follow-up period were 207 +/- 64 pg/ml (mean + SD) in the 10 microgram and 235 +/- 87 pg/ml in the 30 microgram/day releasing IUD groups. The milk levonorgestrel concentrations were 56 +/- 35 and 57 +/- 34 pg/ml, respectively. The plasma to milk ratio of levonorgestrel was initially 100:15 and at the end of the 3-month follow-up period 100:25. There were no significant differences in the milk and plasma concentrations between the study groups. The total amount of levonorgestrel excreted per day in 600 ml breast milk is approximately 0.1 per cent of a daily dose of 30 microgram.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800691     DOI: 10.1016/0010-7824(82)90017-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

Review 1.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 2.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 3.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 4.  Optimizing maternal and neonatal outcomes with postpartum contraception: impact on breastfeeding and birth spacing.

Authors:  Aparna Sridhar; Jennifer Salcedo
Journal:  Matern Health Neonatol Perinatol       Date:  2017-01-13

5.  Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUD.

Authors:  Niaree G Hopelian; Rebecca G Simmons; Jessica N Sanders; Katherine Ward; Sabrina Malone Jenkins; Eve Espey; David K Turok
Journal:  BMC Womens Health       Date:  2021-01-21       Impact factor: 2.809

6.  Models and methods to characterise levonorgestrel release from intradermally administered contraceptives.

Authors:  Adnan Al Dalaty; Benedetta Gualeni; Sion A Coulman; James C Birchall
Journal:  Drug Deliv Transl Res       Date:  2021-12-03       Impact factor: 4.617

Review 7.  Intrauterine contraception after cesarean section and during lactation: a systematic review.

Authors:  Norman D Goldstuck; Petrus S Steyn
Journal:  Int J Womens Health       Date:  2013-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.